🔗 Permalink

Inventor profile of:

Jonathan David Garman

City:

Thornhill

Country:

Canada

Published Applications:

Last publication date:

2024-09-12

Top Assignees for applications by Jonathan David Garman

The entities that hold a legal rights for patent applications filed by inventor Garman Jonathan David:

NoNO Inc. 17 Toronto, Canada
NoNo, Inc. 5 Toronto, Ontario, Canada
Nono Inc. 5 , Canada
NoNO NC. 1 Toronto, Canada
NoNO, Inc. 1 Toronto, ON Canada

Recent patent applications by Garman Jonathan David

Jonathan David Garman from Thornhill, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-09-12

US20240301003A1

Chemistry; metallurgy

PLASMIN-RESISTANT PEPTIDES FOR IMPROVED THERAPEUTIC INDEX

#2 | 2023-05-04

US20230139826A1

Human necessities

COMBINATION TREATMENT OF STROKE WITH PLASMIN-CLEAVABLE PSD-95 INHIBITOR AND REPERFUSION

#3 | 2023-02-23

US20230055441A1

Chemistry; metallurgy

PLASMIN-RESISTANT PEPTIDES FOR TREATING STROKE AND RELATED CONDITIONS

#4 | 2022-06-09

US20220175880A1

Human necessities

Chloride salt of TAT-NR2B9C

#5 | 2022-03-31

US20220096383A1

Human necessities

LYOPHILIZED FORMULATION OF TAT-NR2B9C WITH ACETYLATION SCAVENGER

#6 | 2020-12-10

US20200384071A1

Human necessities

Chloride salt of TAT-NR2B9C

#7 | 2020-04-23

US20200121755A1

Human necessities

Therapy for subarachnoid hemorrhage and ischemia

#8 | 2019-09-12

US20190275105A1

Human necessities

Prelyophilized, lyophilized and reconstituted formulations comprising TAT-NR2B9C with d-amino acids, histidine and trehalose

#9 | 2019-08-01

US20190231693A1

Human necessities

LYOPHILIZED FORMULATION OF TAT-NR2B9C WITH ACETYLATION SCAVENGER

#10 | 2019-06-13

US20190175689A1

Human necessities

Chloride salt of TAT-NR2B9c

#11 | 2019-02-07

US20190038760A1

Human necessities

CO-ADMINISTRATION OF AN AGENT LINKED TO AN INTERNALIZATION PEPTIDE WITH AN ANTI-INFLAMMATORY

#12 | 2017-05-04

US20170119845A1

Human necessities

Chloride salt of TAT-NR2B9c

#13 | 2017-04-27

US20170112769A1

Human necessities

Lyophilized formulation of TAT-NR2B9C with acetylation scavenger

#14 | 2017-02-16

US20170043030A1

Human necessities

Co-administration of an agent linked to an internalization peptide with an anti-inflammatory

#15 | 2017-02-09

US20170035838A1

Human necessities

Lyophilized formulation comprising tat-NR2B9C, histidine and trehalose

#16 | 2016-08-11

US20160228499A1

Human necessities

Therapy for subarachnoid hemorrhage and ischemia

#17 | 2015-07-23

US20150202253A1

Human necessities

Model systems and treatment regimes for treatment of neurological disease

#18 | 2015-05-07

US20150126460A1

Human necessities

Co-administration of an agent linked to an internalization peptide with an anti-inflammatory

#19 | 2015-01-15

US20150018283A1

Chemistry; metallurgy

Methods for treating pain

#20 | 2014-09-18

US20140274906A1

Chemistry; metallurgy

ND2 peptides and methods of treating neurological disease

#21 | 2014-08-21

US20140235619A1

Human necessities

Agents and methods for treating ischemic and other diseases

#22 | 2014-06-12

US20140162957A1

Human necessities

LYOPHILIZED FORMULATION OF TAT-NR2B9C

#23 | 2013-10-10

US20130267470A1

Human necessities

Treatment of penetrative injury to the brain

#24 | 2012-10-25

US20120269733A1

Human necessities

Model systems and treatment regimes for treatment of neurological disease

#25 | 2012-10-04

US20120252731A1

Human necessities

Co-administration of an agent linked to an internalization peptide with an anti-inflammatory

#26 | 2011-10-13

US20110251182A1

Human necessities

Agents and methods for treating ischemic and other diseases

InventorID:

478120 ⎘